- Home
- HUMA vs PSNYW Comparison
HUMA vs PSNYW Comparison
Compare HUMA & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- PSNYW
- Stock Information
- Founded
- HUMA 2004
- PSNYW 2017
- Country
- HUMA United States
- PSNYW Sweden
- Employees
- HUMA N/A
- PSNYW 2547
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- PSNYW Auto Manufacturing
- Sector
- HUMA Health Care
- PSNYW Consumer Discretionary
- Exchange
- HUMA Nasdaq
- PSNYW Nasdaq
- Market Cap
- HUMA 367.6M
- PSNYW 316.6M
- IPO Year
- HUMA N/A
- PSNYW N/A
- Fundamental
- Price
- HUMA $2.34
- PSNYW $0.17
- Analyst Decision
- HUMA Strong Buy
- PSNYW
- Analyst Count
- HUMA 7
- PSNYW 0
- Target Price
- HUMA $13.00
- PSNYW N/A
- AVG Volume (30 Days)
- HUMA 3.4M
- PSNYW 43.4K
- Earning Date
- HUMA 08-12-2025
- PSNYW 03-06-2025
- Dividend Yield
- HUMA N/A
- PSNYW N/A
- EPS Growth
- HUMA N/A
- PSNYW N/A
- EPS
- HUMA N/A
- PSNYW N/A
- Revenue
- HUMA $517,000.00
- PSNYW $2,034,261,000.00
- Revenue This Year
- HUMA N/A
- PSNYW N/A
- Revenue Next Year
- HUMA $896.45
- PSNYW $79.49
- P/E Ratio
- HUMA N/A
- PSNYW N/A
- Revenue Growth
- HUMA N/A
- PSNYW N/A
- 52 Week Low
- HUMA $1.15
- PSNYW $0.09
- 52 Week High
- HUMA $9.79
- PSNYW $0.61
- Technical
- Relative Strength Index (RSI)
- HUMA 50.49
- PSNYW 67.00
- Support Level
- HUMA $2.13
- PSNYW $0.15
- Resistance Level
- HUMA $2.80
- PSNYW $0.18
- Average True Range (ATR)
- HUMA 0.18
- PSNYW 0.01
- MACD
- HUMA 0.01
- PSNYW 0.00
- Stochastic Oscillator
- HUMA 35.69
- PSNYW 69.57
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.